160 related articles for article (PubMed ID: 32844906)
21. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
[TBL] [Abstract][Full Text] [Related]
22. The effect of benznidazole dose among the efficacy outcome in the murine animal model. A quantitative integration of the literature.
Molina I; Perin L; Aviles AS; de Abreu Vieira PM; da Silva Fonseca K; Cunha LM; Carneiro CM
Acta Trop; 2020 Jan; 201():105218. PubMed ID: 31610148
[TBL] [Abstract][Full Text] [Related]
23. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
[TBL] [Abstract][Full Text] [Related]
24. Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi.
Lim S; Collins S; Hamer SA; Tarleton RL; Saunders AB
J Vet Intern Med; 2024; 38(3):1725-1729. PubMed ID: 38500407
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
[TBL] [Abstract][Full Text] [Related]
26. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease.
Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z
Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275
[No Abstract] [Full Text] [Related]
27. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
[TBL] [Abstract][Full Text] [Related]
28. Mother-to-child transmission of congenital Chagas disease, Japan.
Imai K; Maeda T; Sayama Y; Mikita K; Fujikura Y; Misawa K; Nagumo M; Iwata O; Ono T; Kurane I; Miyahira Y; Kawana A; Miura S
Emerg Infect Dis; 2014 Jan; 20(1):146-8. PubMed ID: 24378113
[TBL] [Abstract][Full Text] [Related]
29. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
Jardim E; Takayanagui OM
J Trop Med Hyg; 1994 Dec; 97(6):367-70. PubMed ID: 7966540
[TBL] [Abstract][Full Text] [Related]
30. Benznidazole shortage makes chagas disease a neglected tropical disease in developed countries: data from Spain.
Navarro M; Norman FF; Pérez-Molina JA; López-Vélez R
Am J Trop Med Hyg; 2012 Sep; 87(3):489-90. PubMed ID: 22826485
[TBL] [Abstract][Full Text] [Related]
31. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
[TBL] [Abstract][Full Text] [Related]
32. Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS.
Bisio M; Altcheh J; Lattner J; Moscatelli G; Fink V; Burgos JM; Bournissen FG; Schijman AG; Freilij H
Emerg Infect Dis; 2013; 19(9):1490-2. PubMed ID: 23965334
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.
Matsuo AL; Silva LS; Torrecilhas AC; Pascoalino BS; Ramos TC; Rodrigues EG; Schenkman S; Caires AC; Travassos LR
Antimicrob Agents Chemother; 2010 Aug; 54(8):3318-25. PubMed ID: 20479201
[TBL] [Abstract][Full Text] [Related]
34. Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.
Sperandio da Silva GM; Mediano MFF; Hasslocher-Moreno AM; Holanda MT; Silvestre de Sousa A; Sangenis LHC; Brasil PEAAD; Mejía RA; Fux CP; Cubides JC; Saraiva RM; Brum-Soares LM
J Antimicrob Chemother; 2017 Sep; 72(9):2596-2601. PubMed ID: 28645201
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
[TBL] [Abstract][Full Text] [Related]
36. Recognition for Chagas disease.
Burki T
Lancet Infect Dis; 2019 Jul; 19(7):699. PubMed ID: 31250822
[No Abstract] [Full Text] [Related]
37. Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease.
Francisco AF; Jayawardhana S; Taylor MC; Lewis MD; Kelly JM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082291
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of a novel compound, (e)-1-(4'-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene against Trypanosoma cruzi in mice.
Barrett PA; Beveridge E; Bull D; Caldwell IC; Islip PJ; Neal RA; Woods NC
Experientia; 1982 Mar; 38(3):338-9. PubMed ID: 6804255
[TBL] [Abstract][Full Text] [Related]
40. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
